MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
common stock under...
$22,615K
Proceeds from sale of
common stock,...
$15,926K
Proceeds from issuance of
notes payable and...
$3,738K
Proceeds from credit
facility
$750K
Net cash provided by
financing activities
$30,311K
Canceled cashflow
$12,718K
Net increase
(decrease) in cash and cash...
$8,682K
Canceled cashflow
$21,629K
Repayment of notes payable
$3,703K
Repayment of credit
facility
$3,292K
Payment to investors
pursuant to letter...
$3,242K
Payment of financing
costs
$2,250K
Offering costs for sale of
common stock
$231K
Noncash financing
expenses
$3,061K
Change in fair value of
derivative instruments
$2,631K
Stock compensation
expense
$1,540K
Depreciation and
amortization
$445K
Grant receivable
-$249K
Other liabilities
$159K
Proceeds from sales of
short-term investments
$4,768K
Proceeds from redemption
of short-term...
$3,768K
Proceeds from sale of
property and equipment
$30K
Net cash used in
operating activities
-$20,775K
Net cash used in
investing activities
-$854K
Canceled cashflow
$8,085K
Canceled cashflow
$8,566K
Net loss
-$22,386K
Purchases of short-term
investments
$9,353K
Accounts payable and
accrued expenses
-$5,620K
Other assets
$763K
Change in operating
lease liabilities
-$66K
Gain on sale of assets
$16K
Accretion of discount on
short-term investments
$9K
Purchases of property and
equipment
$67K
Back
Back
Cash Flow
source: myfinsight.com
PLUS THERAPEUTICS, INC. (PSTV)
PLUS THERAPEUTICS, INC. (PSTV)